Beyond lipid metabolism, AMPK also modulates glucose metabolism by promoting glycogen synthesis and improving insulin sensitivity, collectively contributing to alleviating MASLD-related metabolic disturbances [13]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.